Beryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve AUDITED FINANCIAL RESULTS FOR THE ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Beryl Drugs Ltd has scheduled a board meeting on 30th May 2025 at 2:00 PM at its registered office in Indore. The main item on the agenda is to consider and approve the audited financial results for the quarter and full year ended 31st March 2025, along with the audited financial statements (balance sheet, profit & loss, cash flow, and notes). The board will also take on record the statutory auditor's report for FY 2024-25. Additionally, the directors' interest disclosures under Section 184(1) in Form MBP-1 will be noted. The board will also appoint Abhay Bhandari & Associates, Chartered Accountants, as the new internal auditor for FY 2025-2026, and authorise Mr. Sudhir Sethi to sign tender-related documents for the year.
This is a routine advance notice of a board meeting, and no actual financial numbers have been disclosed yet. Retail investors should wait for the audited results to be released on or after 30th May 2025 to assess the company's full-year performance. The new internal auditor appointment is a standard governance item and not unusual.